Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.

STUDY OBJECTIVE--To assess whether long term inhibition of angiotensin converting enzyme with captopril and frusemide or bendrofluazide protects kidney function in diabetic nephropathy. DESIGN--Non-randomised controlled before-after trial of matched hypertensive insulin dependent diabetics with nephropathy treated with captopril and frusemide or bendrofluazide. SETTING--Outpatient diabetic clinic in tertiary referral centre. PATIENTS--Treatment group of 18 hypertensive insulin dependent diabetics with nephropathy (mean age 33), who had not been treated previously. Control group of 13 patients (mean age 32) fulfilling the same entry criteria from a prospective study. INTERVENTIONS--Treatment group was given daily captopril 37.5-100.0 mg and frusemide (mean) 98 mg (10 patients) or bendrofluazide (mean) 4 mg (seven). Treatment was continued for about two and a half years. Controls were not treated. END POINT--Measurement of arterial blood pressure, albuminuria, and glomerular filtration. MEASUREMENTS AND MAIN RESULTS--Baseline values were identical in treated and untreated groups respectively: mean blood pressure 146/93 (SE 3/1) mm Hg v 137/95 (2/1) mm Hg; geometric mean albuminuria 982 (antilog SE 1.2) micrograms/min v 936 (1.2) micrograms/min; and mean glomerular filtration rate 98 (SE 5) ml/min/1.73 m2 v 96 (6) ml/min/1.73 m2. Mean arterial blood pressure fell by 8.7 (1.3) mm Hg with captopril and rose by 6.6 (1.5) mm Hg in controls, (p less than 0.001); Albumin excretion decreased to 390 (1.1) micrograms/min with captopril and rose to 1367 (1.3) micrograms/min in controls (p less than 0.001). The rate of decrease in glomerular filtration rate was lower with captopril (5.8 (0.7) ml/year v 10.0 (1.3) ml/year) (p less than 0.01). Rate of fall in glomerular filtration rate and mean arterial blood pressure were significantly correlated (n = 31, r = 0.37, p less than 0.05). CONCLUSIONS--Captopril is a valuable new drug for treating hypertension in insulin dependent diabetics with nephropathy.

[1]  W. de Oliveira Júnior [The effects of antihypertensive therapy on the quality of life]. , 1989, Arquivos brasileiros de cardiologia.

[2]  H. Parving,et al.  High blood pressure is a major factor in progression of diabetic nephropathy. , 1988, The Journal of diabetic complications.

[3]  H. Parving,et al.  Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetes , 1988, British medical journal.

[4]  A. Breckenridge,et al.  PLACEBO-CONTROLLED COMPARISON OF CAPTOPRIL, ATENOLOL, LABETALOL, AND PINDOLOL IN HYPERTENSION COMPLICATED BY INTERMITTENT CLAUDICATION , 1987, The Lancet.

[5]  D. de Zeeuw,et al.  Reduction of proteinuria by angiotensin converting enzyme inhibition. , 1987, Kidney international.

[6]  M. Marre,et al.  Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. , 1987, British medical journal.

[7]  H. Parving,et al.  Effect of antihypertensive treatment on kidney function in diabetic nephropathy. , 1987, British medical journal.

[8]  H. Aynedjian,et al.  Evidence against increased glomerular pressure initiating diabetic nephropathy. , 1987, Kidney international.

[9]  B. Isaksson,et al.  Diabetic nephropathy: is dietary protein harmful? , 1987, The Journal of diabetic complications.

[10]  D. Cohen,et al.  Effect of protein restriction in insulin dependent diabetics at risk of nephropathy. , 1987, British medical journal.

[11]  S. Ahmad,et al.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. , 1986, British medical journal.

[12]  G. Nyberg,et al.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. , 1986, British medical journal.

[13]  H. Parving,et al.  Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. , 1986, British medical journal.

[14]  G. Klerman,et al.  The effects of antihypertensive therapy on the quality of life. , 1986, The New England journal of medicine.

[15]  B. Brenner,et al.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. , 1986, The Journal of clinical investigation.

[16]  B. Brenner,et al.  Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. , 1986, The Journal of clinical investigation.

[17]  O. Paulson,et al.  Effect of captopril on the cerebral circulation in chronic heart failure , 1986, European journal of clinical investigation.

[18]  P. K. Jensen,et al.  Effects of indomethacin on glomerular hemodynamics in experimental diabetes. , 1986, Kidney international.

[19]  J. Ferriss,et al.  Exchangeable Sodium and Renin in Hypertensive Diabetic Patients With and Without Nephropathy , 1985, Hypertension.

[20]  P. Padfield,et al.  ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: PAST, PRESENT, AND BRIGHT FUTURE , 1985, The Lancet.

[21]  W. Mitch,et al.  A method for estimating nitrogen intake of patients with chronic renal failure. , 1985, Kidney international.

[22]  B. Brenner,et al.  Glomerular actions of angiotensin II. , 1984, The American journal of medicine.

[23]  N. Lassen,et al.  Hemodynamic factors in the genesis of diabetic microangiopathy. , 1983, Metabolism: clinical and experimental.

[24]  H. Parving,et al.  Diabetic Nephropathy and Arterial Hypertension: The Effect of Antihypertensive Treatment , 1983, Diabetes.

[25]  H. Parving,et al.  EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY , 1983, The Lancet.

[26]  R. Bilous,et al.  Monitoring glomerular function in diabetic nephropathy. A prospective study. , 1983, The American journal of medicine.

[27]  B. Brenner,et al.  Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. , 1983, Kidney international.

[28]  C. Mogensen Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy , 1982, British medical journal.

[29]  B. Brenner,et al.  The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. , 1982, The American journal of medicine.

[30]  B. Brenner,et al.  Glomerular hemodynamics in experimental diabetes mellitus. , 1981, Kidney international.

[31]  H. Mortensen Quantitative determination of hemoglobin A1c by thin-layer isoelectric focusing. , 1980, Journal of chromatography.

[32]  P. Watkins,et al.  Can insulin-treated diabetics be given beta-adrenergic blocking drugs? , 1980, British medical journal.

[33]  B. Isaksson Urinary nitrogen output as a validity test in dietary surveys. , 1980, The American journal of clinical nutrition.

[34]  M. Steffes,et al.  The Effects of Goldblatt Hypertension on Development of the Glomerular Lesions of Diabetes Mellitus in the Rat , 1978, Diabetes.

[35]  T. Deckert,et al.  Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. , 1978, Diabetologia.

[36]  B. Brenner,et al.  Mechanism of angiotensin II-induced proteinuria in the rat. , 1977, The American journal of physiology.

[37]  B. Brenner,et al.  Effects of Norepinephrine and Angiotensin II on the Determinants of Glomerular Ultrafiltration and Proximal Tubule Fluid Reabsorption in the Rat , 1975, Circulation research.

[38]  Z. J. Lipowski Letter: Psychosomatic medicine. , 1974, Lancet.

[39]  H. Rifkin,et al.  Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): report of a case. , 1973, Metabolism: clinical and experimental.

[40]  J. Bröchner-Mortensen A simple method for the determination of glomerular filtration rate. , 1972, Scandinavian journal of clinical and laboratory investigation.

[41]  C. Mogensen,et al.  Radioimmunoassay for urinary albumin using a single antibody. , 1970, Scandinavian journal of clinical and laboratory investigation.

[42]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.